Portfolio / Seven retained product programs

Every product stays. Execution follows an order.

HERA Nexus is the near-term commercial wedge. EchoNet and Helios Autonomy are adjacent validation programs. Athena, Aetherion Core, BioForge + GenovaX, and PX-Phantom remain long-horizon research programs behind explicit evidence and capital gates.

7 product programsNo retained product removed
1 commercial wedgeHERA Nexus concentrates near-term execution
3 operating horizonsCommercial, adjacent validation, and long-horizon R&D
1 evidence standardEvery public claim must survive diligence

Portfolio sequencing

One company—not seven simultaneous burn centers.

The portfolio can remain ambitious when management concentrates people and capital according to present evidence rather than treating every long-range concept as an equal operating priority.

Commercial wedge / Artificial intelligence

HERA Nexus

Development
  1. Prototype
  2. Development
01 / Current maturityDevelopment
02 / Current objective

Validate Technical Evidence Review & Approval as one human-supervised workflow with a qualified design partner and measurable operating outcomes.

03 / Next evidence gate

Controlled external evaluation, security artifacts, published evidence records, and a documented path to a paid pilot.

Review HERA Nexus

Canonical product directory

Seven programs. Seven explicit next gates.

This directory uses the same canonical maturity and sequencing data as the homepage, investor overview, and evidence registry.

01 / Commercial wedgeDevelopment

HERA Nexus

Artificial intelligence. Validate Technical Evidence Review & Approval as one human-supervised workflow with a qualified design partner and measurable operating outcomes.

Next evidence gate: Controlled external evaluation, security artifacts, published evidence records, and a documented path to a paid pilot.

Open program
02 / Long-horizon R&DDevelopment

Athena

Clinical decision support. Build evidence-linked chart synthesis and review summaries that keep a named clinician accountable for every output, ahead of any clinical evaluation.

Next evidence gate: Retrospective de-identified dataset, a documented review protocol, clinician-in-the-loop error analysis, and an independent methodology review.

Open program
03 / Adjacent validationDevelopment

EchoNet

Resilient communications. Demonstrate bounded coordination and graceful degradation in a controlled network environment.

Next evidence gate: Documented test method, network conditions, repeatable results, and failure analysis.

Open program
04 / Adjacent validationDevelopment

Helios Autonomy

Autonomous systems. Test accountable perception, planning, escalation, and human intervention boundaries in simulation.

Next evidence gate: Scenario suite, intervention criteria, recorded decisions, and independent technical review.

Open program
05 / Long-horizon R&DDevelopment

Aetherion Core

Emerging compute. Define and test the most consequential assumptions in the post-silicon and hybrid compute architecture.

Next evidence gate: Published architecture note, simulation method, reproducible model, and clearly labeled limitations.

Open program
06 / Long-horizon R&DDevelopment

BioForge + GenovaX

Biotechnology. Develop evidence-aware research workflows and identify one bounded biotechnology use case for external review.

Next evidence gate: Defined research question, responsible-review process, reproducible workflow, and qualified domain partner.

Open program
07 / Long-horizon R&DDevelopment

PX-Phantom

Aerospace systems. Convert the aerospace thesis into a simulation-led research program with explicit engineering constraints.

Next evidence gate: Requirements baseline, simulation assumptions, engineering review, and dated test plan.

Open program
Engineers reviewing an evidence and authority review wall in a low-lit research control room.
Shared operating architectureEvidence / Authority / Governance

Shared operating architecture

Compounding must be demonstrated—not declared.

Planckchron's platform thesis is that specific intelligence, evidence, governance, and review patterns can transfer across domains while every product retains its own technical and regulatory requirements.

01

Human authority

Accountable owners, approval points, intervention boundaries, and stop criteria remain explicit.

02

Evidence

Claims, methods, configurations, limitations, decisions, and review records remain traceable.

03

Intelligence

HERA coordinates context and review without converting uncertain model output into unqualified fact.

04

Security and governance

Access, privacy, misuse boundaries, and responsible deployment requirements are defined before scale.

05

Program-specific validation

Every domain retains its own technical, commercial, legal, safety, and regulatory evidence gates.

Design partners and investors

Start with one measurable workflow and one accountable owner.

Planckchron is seeking qualified partners who will define the problem, baseline, evidence plan, review boundary, success criteria, and stop criteria before expanding technology scope.